Nov 12 (Reuters) - Celgene Corp CELG.O :
* SKYHAWK THERAPEUTICS ANNOUNCES A SECOND MULTI-TARGET COLLABORATION AGREEMENT WITH CELGENE TO DISCOVER AND DEVELOP NOVEL SMALL MOLECULES THAT MODULATE RNA SPLICING
* SKYHAWK THERAPEUTICS - TO RECEIVE $80 MILLION UPFRONT PAYMENT AND IS ELIGIBLE FOR POTENTIAL MILESTONE PAYMENTS AND ROYALTIES
* SKYHAWK THERAPEUTICS - CELGENE TO RECEIVE EXCLUSIVE OPTIONS TO LICENSE A NUMBER OF SKYHAWK'S PRODUCT CANDIDATES